![Nihal Sinha](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Nihal Sinha
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Ensoma, Inc.
![]() Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Nihal Sinha tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | General Counsel | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Brown University | College/University | Doctorate Degree | |
University of Pittsburgh | College/University | Doctorate Degree | |
University of Cambridge | College/University | Graduate Degree | |
Fish & Neave LLP
![]() Fish & Neave LLP Miscellaneous Commercial ServicesCommercial Services Fish & Neave operates as a law firm. It specializes in specializes in intellectual property issues involving patents, trademarks, and copyrights. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Johns Hopkins University | College/University | Graduate Degree | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Graduate Degree | |
Tufts University | College/University | Graduate Degree | |
Salem State University | College/University | Undergraduate Degree | |
University of Delaware | College/University | Undergraduate Degree | |
5AM Venture Management LLC
![]() 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Shire Pharmaceuticals, Inc.
![]() Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal | |
AH Capital Management LLC
![]() AH Capital Management LLC Investment ManagersFinance AH Capital Management LLC (AH Capital Management) is a venture capital firm founded in 2009 by Marc Lowell Andreessen and Ben A. Horowitz. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
UNIQURE N.V. | Biotechnology | Director/Board Member | |
Harvard Business School | College/University | Graduate Degree | |
Fordham University School of Law | College/University | Graduate Degree | |
PULMATRIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
AKCEA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Code Ocean, Inc.
![]() Code Ocean, Inc. Packaged SoftwareTechnology Services Code Ocean, Inc. operates as a cloud-based computational reproducibility platform. It provides researchers and developers to share, discover and run code published in academic journals and conferences. The company was founded by Simon Adar in 2015 and is headquartered in New York, NY. | Packaged Software | Director/Board Member | |
BlueRock Therapeutics Canada ULC
![]() BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Biotechnology | Chief Operating Officer | |
Depixus SAS
![]() Depixus SAS Miscellaneous Commercial ServicesCommercial Services Depixus SAS is a life science technology company based in Paris, France. Depixus is pioneering ground-breaking magna™ technology based on magnetic force spectroscopy, revealing dramatic new insights into complex biomolecular interactions at the single molecule level. The French company was founded by Gordon Hamilton and has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
M12 Ventures
![]() M12 Ventures Investment ManagersFinance M12 Ventures (M12) is a venture capital subsidiary of Microsoft Corp. founded in 2016. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Rallybio LLC
![]() Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Rallybio Holdings LLC
![]() Rallybio Holdings LLC Medical/Nursing ServicesHealth Services Rallybio Holdings LLC engages in the provision of healthcare services. The company is headquartered in New Haven, CT. | Medical/Nursing Services | Director/Board Member | |
Iterum Therapeutics International Ltd.
![]() Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics International Ltd. engages in the development of clinical-stage pharmaceutical products. The company was founded in 2015 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
Iterum Therapeutics US Holding Ltd.
![]() Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Iterum Therapeutics US Holding Ltd. operates as a clinical-stage pharmaceutical company. The company was founded in 2018 and is headquartered in Chicago, IL. | Financial Conglomerates | Director/Board Member | |
Lacerta Therapeutics, Inc.
![]() Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Lacerta Therapeutics, Inc. operates as a a clinical stage gene therapy company. The firm engages in development, production, and application of AAV vectors. The company was founded by Nicholas Muzyczka, Barry Byrne, Arun Srivastava, Coy Heldermon, Sergei Zolothukin, Kenneth Warrington, Ronald Mandel, Toadd E. Golde and Edgardo Rodriguez in 2017 and is headquartered in Alachua, FL. | Biotechnology | Director/Board Member | |
MODERNA, INC. | Biotechnology | Corporate Officer/Principal | |
PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
Dianthus Therapeutics, Inc. (Massachusetts)
![]() Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Dianthus Therapeutics OpCo, Inc. provides heath care services. The company was founded by Jonathan Violin and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
Disc Medicine Opco, Inc.
![]() Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Huue, Inc.
![]() Huue, Inc. BiotechnologyHealth Technology Huue, Inc. develops biotechnology to provide indigo dyeing solutions to the textile and fashion industry. The company was founded by Michelle Zhu and Tammy Hsu in 2018 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Artificial, Inc.
![]() Artificial, Inc. Packaged SoftwareTechnology Services Artificial, Inc. engages in the development of software to close the loop between humans and robots in the lab. It offers flow scheduler, elements SDK, flow tools, and substrate core. The company is headquartered in Palo Alto, CA. | Packaged Software | Director/Board Member | |
MONTE ROSA THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer | |
501 ACQU | Financial Conglomerates | Chief Executive Officer | |
BlueRock Therapeutics LP
![]() BlueRock Therapeutics LP Miscellaneous Commercial ServicesCommercial Services Part of Bayer AG, BlueRock Therapeutics LP is a clinical stage cell therapy company focused on creating cellular medicines to reverse devastating diseases. The company is based in Cambridge, MA. In late 2019, BlueRock became a wholly owned, independently operated subsidiary of Bayer AG as a cornerstone of its newly formed cell & gene therapy platform. The company's culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that they are all part of something bigger than themselves. BlueRock Therapeutics' lead clinical program, Bemdaneprocel (BRT-DA01), is in phase I clinical trials for Parkinson's disease. BlueRock Therapeutics was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, the impact investing arm of Bayer AG. Seth Ettenberg has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Chief Operating Officer | |
Avoro Ventures LLC
![]() Avoro Ventures LLC Investment ManagersFinance Avoro Ventures LLC (Avoro Ventures) is a venture capital subsidiary of Avoro Capital Advisor LLC founded in 2020. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Kyowa Kirin, Inc. | Director/Board Member | ||
RALLYBIO CORPORATION | Biotechnology | Director/Board Member Director/Board Member | |
DISC MEDICINE, INC. | Biotechnology | Director/Board Member | |
Longitude Capital | Corporate Officer/Principal | ||
Arix Bioscience /Venture Capital/
![]() Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York. | Investment Managers | Private Equity Investor | |
Seamless Therapeutics
![]() Seamless Therapeutics Packaged SoftwareTechnology Services Seamless Therapeutics is a German company that is changing the paradigm of gene editing by unlocking the full potential of recombinases. The company is based in Dresden, Germany. The company is developing a pipeline of disease-modifying product candidates across a broad spectrum of indications to expand the therapeutic potential of gene editing. | Packaged Software | Chief Executive Officer | |
DIANTHUS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
JFYNetworks, Inc | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 44 |
Regno Unito | 3 |
Paesi Bassi | 2 |
Canada | 2 |
Francia | 2 |
Settori
Health Technology | 23 |
Consumer Services | 11 |
Finance | 8 |
Commercial Services | 5 |
Technology Services | 4 |
Posizioni
Director/Board Member | 48 |
Independent Dir/Board Member | 16 |
Corporate Officer/Principal | 15 |
Graduate Degree | 7 |
Private Equity Investor | 7 |
Contatti più connessi
Insiders | |
---|---|
Kush Parmar | 32 |
Mark Chin | 25 |
Paula Soteropoulos | 13 |
Min Wang | 11 |
Kouki Harasaki | 10 |
Albert Seymour | 7 |
- Borsa valori
- Insiders
- Nihal Sinha
- Connessioni Società